Activin A, a member of the
transforming growth factor-beta superfamily, is a critical modulator of
inflammation and plays a key role in controlling the
cytokine cascade that drives the inflammatory response. However, the role of
activin A in inflammatory
kidney diseases remains unknown. To address this issue, we examined here whether
activin A can be detected in the kidney and/or urine from patients with
antineutrophil cytoplasmic antibody (
ANCA) -associated vasculitis (AAV). Fifty-one patients who had been diagnosed with AAV and were treated in our department between November 2011 to March 2018 were included in this study. Forty-one patients had renal complications (renal AAV). Serum and urinary
activin A levels were measured by
enzyme-linked
immunosorbent assay. Correlation of urinary
activin A concentration with clinical parameters was analyzed. Urinary
activin A was undetectable in healthy volunteers. In contrast, urinary
activin A concentration was significantly increased in patients with renal AAV but not in those with non-renal AAV. Urinary
activin A concentration decreased rapidly after immunosuppressive treatment. There was a significant correlation of urinary
activin A level with urinary
protein, L-FABP, and NAG. Histologic evaluation revealed that urinary
activin A levels were significantly higher in patients with cellular crescentic glomeruli than in those lacking this damage. In situ hybridization demonstrated that the
mRNA encoding the
activin A βA subunit was undetectable in normal kidneys but accumulated in the proximal tubules and crescentic glomeruli of the kidneys of patients with renal AAV. Immunostaining showed that
activin A protein also was present in the proximal tubules, crescentic glomeruli, and macrophages infiltrating into the interstitium in the kidneys of patients with renal AAV. These data suggested that urinary
activin A concentration reflects renal
inflammation and tubular damage in AAV and may be a useful
biomarker for monitoring renal AAV.